Product Information
COLESEVELAM 625 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.2608 per EA under NDC 69452015825. Its NADAC has been published 315 times since Aug 12, 2020.
FDA first approved this application on Sep 13, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
625 mg/1
Manufacturer
Bionpharma Inc.NDC
69452015825
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
COLESEVELAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208670FDA Approved
9/13/2019
TE Code
AB
On Market Since
12/2/2019
Pharmacological Classes
Price Statistics
The NADAC for COLESEVELAM 625 MG TABLET has been published 315 times since Aug 12, 2020, and over the history we have for it it has declined 55.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2608 per EA |
|---|---|
| All-time high | $0.6152 (Jan 13, 2021) |
| All-time low | $0.1763 (Jul 17, 2024) |
| 52-week high | $0.2904 |
| 52-week low | $0.2608 |
| Median price | $0.3117 |
| Average price | $0.3539 |
| Largest weekly change | +56.2% (May 17, 2023) |
| Weeks tracked | 315 |
| Tracking since | Aug 12, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of COLESEVELAM 625 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for COLESEVELAM 625 MG TABLET, manufactured by Bionpharma Inc., is $0.2608 per EA (NDC 69452015825), effective Aug 19, 2026.
How has the price of COLESEVELAM 625 MG TABLET changed over time?
Over the history we have for it, the NADAC for COLESEVELAM 625 MG TABLET has declined 55.1%. It has been tracked across 315 weekly CMS publications since Aug 12, 2020.
What are the highest and lowest recorded NADAC prices for COLESEVELAM 625 MG TABLET?
Since Aug 12, 2020, the NADAC for COLESEVELAM 625 MG TABLET has ranged from a low of $0.1763 (Jul 17, 2024) to a high of $0.6152 (Jan 13, 2021), with a median of $0.3117 per EA.
Are there cheaper alternatives to COLESEVELAM 625 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as COLESEVELAM 625 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures COLESEVELAM 625 MG TABLET?
COLESEVELAM 625 MG TABLET (NDC 69452015825) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.